Oxidative stress and redox signalling in cardiac hypertrophy and heart failure
AUTOR(ES)
Seddon, Mike
FONTE
BMJ Group
RESUMO
Substantial evidence suggests the involvement of oxidative stress in the pathophysiology of congestive heart failure and its antecedent conditions such as cardiac hypertrophy and adverse remodelling after MI. Oxidative stress describes an imbalance between antioxidant defences and the production of reactive oxygen species (ROS), which at high levels cause cell damage but at lower levels induce subtle changes in intracellular signalling pathways (termed redox signalling). ROS are derived from many sources including mitochondria, xanthine oxidase, uncoupled nitric oxide synthases and NADPH oxidases. The latter enzymes are especially important in redox signalling, being implicated in the pathophysiology of hypertension and atherosclerosis, and activated by diverse pathologically relevant stimuli. We review the contribution of ROS to heart failure pathophysiology and discuss potential therapies that may specifically target detrimental redox signalling. Indeed, drugs such as ACE inhibitors and statins may act in part through such mechanisms. A better understanding of redox signalling mechanisms may enable the development of new targeted therapeutic strategies rather than the non‐specific antioxidant approaches that have to date been disappointing in clinical trials.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1994416Documentos Relacionados
- Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy
- Oxygen, oxidative stress, hypoxia, and heart failure
- Distinct functions of junD in cardiac hypertrophy and heart failure
- Inflammation and oxidative stress in heart failure: effects of exercise intensity and duration
- Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure